+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gaster D"

Gaster D - API Insight, 2022 - Product Thumbnail Image

Gaster D - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Gaster D- Drug Insight, 2019 - Product Thumbnail Image

Gaster D- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Gaster D market is a segment of the Gastrointestinal Drugs market that focuses on drugs used to treat digestive disorders. These drugs are used to treat a variety of conditions, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Gaster D drugs are typically prescribed by gastroenterologists and other healthcare professionals. They are available in both prescription and over-the-counter forms. The Gaster D market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. Other companies in the market include Allergan, Amgen, Bristol-Myers Squibb, Eli Lilly, and Novartis. Show Less Read more